To our surprise, the ectopic expression of ER(α) in MDA-MB-231 cells enhanced the expression of IL-20 at both the RNA and protein levels by approximately ~2-fold in the presence or absence of estrogen, indicating that ER(α) activated IL-20 expression in the triple negative breast cancer cell line (Figure 1E). This evidence concerns the gene IL20 and triple-negative breast carcinoma.